The ImmunoLogik wishes all people involved in the project, partners and supporters a merry Christmas and a happy New Year 2019.
We are grateful for the support received and various engagement from countless companions in 2019. This gives us confidence to continue resolutely and with full vigor on the chosen path in future.
The ImmunoLogik and the university hospital Erlangen decided to continue their successful cooperation and agreed on an extension of the cooperation contract until September 2019.
The cooperation was and is still an important building block for the development of the innovative lead candidate IML-106 for the efficient and essential treatment of HIV patients who have exploited all available means of the modern therapy and would die due to the unavoidable outbreak of AIDS.